PATTY FLEMING: Open Payments
NPI 1679095798 · ONTARIO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,013 in 61 payments from 17 companies in 2025. Trend: 2023 $1,257 · 2024 $1,545 · 2025 $1,013
Food & beverage: $1,013
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $403 |
| Lundbeck LLC | 4 | $67 |
| Astellas Pharma US Inc | 3 | $62 |
| Amgen Inc. | 3 | $58 |
| GlaxoSmithKline, LLC. | 3 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $53 |
| Optinose US, Inc. | 2 | $51 |
| AstraZeneca Pharmaceuticals LP | 2 | $40 |
| Collegium Pharmaceutical, Inc. | 2 | $39 |
| Novartis Pharmaceuticals Corporation | 2 | $33 |
Products named: VRAYLAR, UBRELVY, REXULTI, JARDIANCE, Veozah, OTEZLA, Xhance, QULIPTA.
Industry payments across OH — which companies pay providers there.
